Current controversies in the USA regarding vaccine safety

References

• Chen RT, Rastogi SC, Mullen JR et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine12, 542–550 (1994).
   PubMed Web of Science ®Google Scholar
• Gust D, Weber D, Weintraub E, Kennedy A, Soud F, Burns A. Physicians who do and do not recommend children get all vaccinations. J. Health Commun.13, 573–582 (2008).
   PubMed Web of Science ®Google Scholar
• Offit PA, Davis RL, Gust D. Vaccine safety. In: Vaccines (5th Edition). Plotkin SA, Orenstien WA, Offit PA (Eds). Saunders Elsevier, PA, USA, 1629–1650 (2008).
   Google Scholar
• Allred NJ, Shaw KM, Santibanez TS, Rickert DL, Santoli JM. Parental vaccine safety concerns: results from the National Immunization Survey, 2001–2002. Am. J. Prev. Med.28(1), 221–224 (2005).
   PubMed Web of Science ®Google Scholar
• Gust DA, Strine TW, Maurice E. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics114, E16–E22 (2004).
   PubMed Web of Science ®Google Scholar
• Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N. Engl J. Med.360(19), 1981–1988 (2009).
   PubMed Web of Science ®Google Scholar
• Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and why. Pediatrics122, 718–725 (2008).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Multistate measles outbreak associated with an international youth sporting event – Pennsylvania, Michigan, and Texas, August–September 2007. MMWR Morb. Mortal. Wkly. Rep.57(7), 169–173 (2008).
   Google Scholar
• Centers for Disease Control and Prevention. Outbreak of measles – San Diego, California, January–February 2008. MMWR Morb. Mortal. Wkly. Rep.57(7), 203–206 (2008).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Invasive Haemophilus influenzae type b disease in five young children – Minnesota 2008. MMWR Morb. Mortal. Wkly. Rep.58(3), 58–60 (2009).
   PubMedGoogle Scholar
• Glanz JM, McClure DL, Magid DJ et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics123, 1446–1451 (2009).
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Murch SH, Linnell J et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet351, 637–641 (1998).
   PubMed Web of Science ®Google Scholar
• Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hashika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig. Dis. Sci.45, 723–729 (2000).
   PubMed Web of Science ®Google Scholar
• D’Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics118, 1664–1675 (2006).
   PubMedGoogle Scholar
• DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin. Pharmacol. Ther.82(6), 756–759 (2007).
   PubMed Web of Science ®Google Scholar
• Murch S. A statement by Dr Simon Murch. Allegations concerning our 1998 study. Lancet363, 821–822 (2004).
   Google Scholar
• The Editors of the Lancet. Retraction – ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet375, 445 (2010).
   PubMed Web of Science ®Google Scholar
• Offit PA. Autism’s False Prophets. Bad science, Risky Medicine, and the Search for a Cure. Columbia University Press, NY, USA (2008).
   Google Scholar
• Institute of Medicine. Immunization Safety Review: Vaccines and Autism. National Academies Press, Washington DC, USA (2004).
   Google Scholar
• Schechter R, Grether JK. Continuing increases in autism reported to California’s developmental services system: mercury in retrograde. Arch. Gen. Psychiatry65(1), 19–24 (2008).
   PubMed Web of Science ®Google Scholar
• Baker JP. Mercury, vaccines, and autism: one controversy, three histories. Am. J. Public Health98, 244–253 (2008).
   PubMed Web of Science ®Google Scholar
• Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics104, 568–569 (1999).
   PubMed Web of Science ®Google Scholar
• Offit PA. Vaccines and autism revisited – the Hannah Poling case. N. Engl. J. Med.358(20), 2089–2091 (2008).
   Google Scholar
• Luño AR. Ethical reflections on vaccines using cells from aborted fetuses. Natl Cathol. Bioeth. Q.6(3), 453–459 (2006).
   Google Scholar
• Pruss AR. Complicity, fetal tissue, and vaccines. Natl Cathol. Bioeth. Q.6(3), 461–470 (2006).
   Google Scholar
• Fisher R, Darrow DH, Tranter M, Williams JV. Human papillomavirus vaccine: recommendations, issues and controversies. Curr. Opin. Pediatr.20, 441–445 (2008).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). National, state and local area vaccination coverage – among adolescents, age 13 to 17 years, US – 2008. MMWR Morb. Mortal. Wkly. Rep.58(36), 997–1001 (2009).
   PubMedGoogle Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.56(RR 2), 1–24 (2007).
   PubMedGoogle Scholar
• Joura EA, Leodolter S, Hernandez-Avila M et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet369, 1693–1702 (2007).
   PubMed Web of Science ®Google Scholar
• FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med.356, 1915–1927 (2007).
   PubMed Web of Science ®Google Scholar
• Slade BA, Leide L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA302(7), 750–757 (2009).
   PubMed Web of Science ®Google Scholar
• Haug C. The risks and benefits of HPV vaccination. JAMA302, 795–796 (2009).
   PubMed Web of Science ®Google Scholar
• Charo RA. Politics, parents, and prophylaxis – mandating HPV vaccinations in the United States. N. Engl. J. Med.336(19), 1905–1908 (2007).
   Google Scholar
• Ohri LK. HPV vaccine: immersed in controversy. Ann. Pharmacother.41, 1899–1902 (2007).
   Google Scholar
• Eaton DK, Kann L, Kinchen S et al. Youth risk behavior surveillance – United States, 2005. Surveillance Summaries. MMWR Morb. Mortal. Wkly. Rep.55, 1–108 (2006).
   PubMedGoogle Scholar
• Greeberg DP, Wirsing von Kőnig C-H, Heininger U. Health burden of pertussis in infants and children. Pediatr. Infect. Dis. J.24(5), S39–S43 (2005).
   Google Scholar
• Omer SB, Pan WKY, Halsey NA et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA296, 1757–1763 (2006).
   PubMed Web of Science ®Google Scholar
• Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch. Dis. Child.49, 46–49 (1974).
   PubMed Web of Science ®Google Scholar
• Brown NJ, Berkovic SF, Scheffer IE. Vaccination, seizures and ‘vaccine damage’. Curr. Opin. Neurol.20, 181–187 (2007).
   PubMed Web of Science ®Google Scholar
• Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr. Infect. Dis. J.6, 364–371 (1984).
   Google Scholar
• Miller DL, Ross EM, Alderslade R et al. Pertussis immunization and serious acute neurological illness in children. Br. Med. J.262, 1595–1599 (1981).
   Google Scholar
• Robinson RJ. The whooping-cough immunization controversy. Arch. Dis. Child.56, 577–580 (1981).
   Google Scholar
• Baker JP. The Pertussis Vaccine Controversy in Great Britain, 1974–1986. Vaccine21, 4003–4010 (2003).
   PubMedGoogle Scholar
• Ray P, Hayward J, Michelson D. Encephalopathy after whole-cell pertussis or measles vaccination: Lack of evidence for a causal association in a retrospective case–control study. Pediatr. Infect. Dis. J.25, 768–773 (2006).
   PubMed Web of Science ®Google Scholar
• Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine25, 570–576 (2007).
   PubMed Web of Science ®Google Scholar
• Hilton S, Petticrew M, Hunt K. ‘Combined vaccines are like a sudden onslaught to the body’s immune system’: parental concerns about vaccine ‘overload’ and ‘immune vulnerability’. Vaccine24, 4321–4327 (2006).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Simultaneous administration of varicella vaccine and other recommended childhood vaccines – United States, 1995–1999. MMWR Morb. Mortal. Wkly. Rep.50, 1058–1061 (2001).
   PubMedGoogle Scholar
• Halsey N. Increased mortality after high-titer measles vaccines: too much of a good thing. Pediatr. Infect. Dis. J.12, 462–465 (1993).
   PubMedGoogle Scholar
• Gregson AL, Edelma R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol. Allergy Clin. N. Am.23, 649–664 (2003).
   PubMedGoogle Scholar
• Pickering LK, Orenstein WO. Active Immunization. In: Principles and Practice of Pediatric Infectious Diseases (3rd Edition). Long SS, Pickering LK, Prober CG (Eds). Elsevier Inc., PA, USA, 48–51 (2008).
   Google Scholar
• Offit PA, Quarles J, Gerber MA et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics109, 124–129 (2002).
   PubMed Web of Science ®Google Scholar
• Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers’ influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics118, E1287–E1292 (2006).
   Web of Science ®Google Scholar